Skip to Content

MD Anderson Events

Innovative antibody-based cancer drugs with integrated diagnostics against novel targets discovered from the OGAP® proteomic database

Innovative antibody-based cancer drugs with integrated diagnostics against novel targets discovered from the OGAP® proteomic database

Oxford Bio Therapeutics Pipeline Presentation: Innovative antibody-based cancer drugs with integrated diagnostics against novel targets discovered from the OGAP® proteomic database

Jon Terrett, PhD, Chief Scientific Officer
Christian Rohlff, PhD, Chief Executive Officer

Date: 8/2/13, 9am to 10:30am
Time: 8/2/13, 9am to 10:30am
Location: FCT2.4144 Training Room A
Format: Seminar/Conference
Contact: Luetta Allen - (713) 563-3545 - lhallen@mdanderson.org